On the occasion of World Adherence Day, the Moroccan pharmaceutical laboratory Cooper Pharma organized the first Therapeutic Adherence Forum, dedicated to the management of hypertension. The event brought together healthcare professionals to address the critical public health issue of treatment continuity.
Hypertension is a leading risk factor for cardiovascular disease in Morocco, with low patient adherence to medication regimens significantly undermining treatment effectiveness. The forum aimed to analyze the causes of this non-adherence and propose concrete solutions.
Discussions highlighted the multifactorial nature of the problem, involving patient education, the physician-patient relationship, and the accessibility of care. Experts emphasized the need for a coordinated national strategy to improve long-term health outcomes.
The initiative by Cooper Pharma underscores the growing recognition within the Moroccan healthcare sector of adherence as a pivotal component for controlling chronic diseases and reducing associated complications.
